Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K D Chavin

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2009
The use of drotrecogin alfa (activated) in solid organ transplant patients: a case seriesS Berkman, N A Weimert, D J Taber, et al.
Transplantation|April 27, 1995
Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2J Lin, R W Yon, K D Chavin, et al.
Transplantation Proceedings|December 23, 2008
Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantationD J Taber, N A Weimert, F Henderson, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1995
Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expressionJ Lin, T W Gettys, L Qin, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1995
CD3 and CD2 ligation alters CD49d epitope expressionJ Lin, L Qin, K D Chavin, et al.
Biochemical and Biophysical Research Communications|May 31, 1988
Decreased Epstein-Barr virus-induced transformation, and elevated 2-5A synthetase and RNase L activity in peripheral blood mononuclear cells from patients treated with recombinant interferon alfa 2bG E Fronko, R J Suhadolnik, E C Vonderheid, et al.
Transplantation Proceedings|February 1, 1991
Murine CD2 mediates cellular immune responses in vivoJ S Bromberg, K D Chavin, H T Lau, et al.
Transplantation|December 1, 1992
Prolongation of rat pancreatic islet allograft survival by anti-CD2 monoclonal antibody treatmentJ H Roark, A M Posselt, L Campos, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 22, 2013
Improving transplant patient safety through pharmacist discharge medication reconciliationC R Musgrave, N A Pilch, D J Taber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993
Production and characterization of soluble and transmembrane murine CD2. Demonstration that CD48 is a ligand for CD2 and that CD48 adhesion is regulated by CD2A J Kaplan, K D Chavin, H Yagita, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 28, 2009
The use of drotrecogin alfa (activated) in solid organ transplant patients: a case seriesS Berkman, N A Weimert, D J Taber, et al.
Transplantation|April 27, 1995
Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2J Lin, R W Yon, K D Chavin, et al.
Transplantation Proceedings|December 23, 2008
Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantationD J Taber, N A Weimert, F Henderson, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1995
Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expressionJ Lin, T W Gettys, L Qin, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1995
CD3 and CD2 ligation alters CD49d epitope expressionJ Lin, L Qin, K D Chavin, et al.
Biochemical and Biophysical Research Communications|May 31, 1988
Decreased Epstein-Barr virus-induced transformation, and elevated 2-5A synthetase and RNase L activity in peripheral blood mononuclear cells from patients treated with recombinant interferon alfa 2bG E Fronko, R J Suhadolnik, E C Vonderheid, et al.
Transplantation Proceedings|February 1, 1991
Murine CD2 mediates cellular immune responses in vivoJ S Bromberg, K D Chavin, H T Lau, et al.
Transplantation|December 1, 1992
Prolongation of rat pancreatic islet allograft survival by anti-CD2 monoclonal antibody treatmentJ H Roark, A M Posselt, L Campos, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 22, 2013
Improving transplant patient safety through pharmacist discharge medication reconciliationC R Musgrave, N A Pilch, D J Taber, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1993
Production and characterization of soluble and transmembrane murine CD2. Demonstration that CD48 is a ligand for CD2 and that CD48 adhesion is regulated by CD2A J Kaplan, K D Chavin, H Yagita, et al.
Pageof 6